24 febrero 2015
An investigational drug appears to cut the risk of severe asthma attacks in half for patients who have difficulty controlling the disorder with standard medications, according to results from two multicenter clinical trials.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/KcqGYAtU_As/150224091734.htm
